Currently browsing tag

china

China approves use of GSK vaccine Cervarix for cervical cancer

Drugmaker GlaxoSmithKline Plc said on Monday the China Food and Drug Administration (CFDA) has approved its human papillomavirus (HPV) vaccine, Cervarix, for use in the country to help women fight cervical cancer. GSK's China unit said in a statement Cervarix will be the first HPV vaccine licensed for use in the country and is expected to be launched there in early 2017. Cervical cancer is the second most common cancer in women aged between 15 to 44 years in China, with an estimated 130,000 new cases each year, it said.

China tightens controls on paid-for internet search ads

China's internet regulator said on Saturday that search engines should tighten management of paid-for ads in search results, making clear which results are paid-for and limiting their numbers. Chinese regulators last month imposed limits on the number of lucrative healthcare adverts carried by Baidu Inc following the death of a student who underwent an experimental cancer treatment which he found using China's biggest internet search engine. Wei Zexi, 21, died in April of a rare form of cancer, and the case sparked widespread public anger.

Exclusive: Chinese, Japanese suitors eye $4 billion sale of CIT plane leasing unit – sources

SINGAPORE/HONG KONG (Reuters) – U.S. lender CIT Group Inc has kicked off the sale of its aircraft leasing assets by inviting more than a dozen entities to consider bidding, including China's HNA Group, Industrial and Commercial Bank of China's ICBC Leasing, and Japan's Orix Corp , sources familiar with the matter said. The sale of CIT's Commercial Air unit could fetch between $3 billion to $4 billion, with Century Tokyo Leasing , sovereign wealth fund China Investment Corp, CDB Leasing, plus some global pension funds and insurers, also invited to bid for the assets, the sources added.

China’s Wanda plans $2.3 bn investment in hospitals

Chinese conglomerate Wanda is venturing into healthcare, it said Wednesday, with a $2.3 billion investment in three hospitals in China, to be managed by a British company. Wanda, owned by China's richest man Wang Jianlin, has its origins in property development but is diversifying into areas ranging from entertainment to e-commerce as China's economy evolves. Wanda plans to fund hospitals in commercial hub Shanghai, southwestern metropolis Chengdu and the port city of Qingdao, the firm said in a statement, adding the 15 billion yuan ($2.3 billion) investment is the largest healthcare investment ever by a Chinese company.

Novartis hit by China, emerging market slowdown: CEO on CNBC

Drugmaker Novartis has been hit by a slowdown in emerging markets, particularly in China, where previously double-digit growth has decelerated to mid-single digits, Chief Executive Joe Jimenez said in an interview with CNBC on Friday. Jimenez' comments echoed concerns expressed on Thursday by U.S. Federal Reserve Chair Janet Yellen, who said the outlook in emerging markets including China have led to volatility. Despite the increasing risks, Jimenez said the Swiss company was not pulling back from emerging markets, rather relying on the strength of generics in China to drive business growth.

Death toll from China blasts rises to 104, Xi urges changes

By Megha Rajagopalan TIANJIN, China (Reuters) – The death toll from two massive explosions that tore through an industrial area in the northeastern Chinese port of Tianjin has risen to 104, state media said on Saturday, as China's president urged improvements in workplace safety. Chinese President Xi Jinping said authorities should learn the lessons paid for with blood in Wednesday warehouse blasts, according to the official Xinhua news agency. China evacuated residents who had taken refuge in a school near the site of two huge explosions, state media said, after a change in wind direction on Saturday prompted fears that toxic chemical particles could be blown inland.

China’s ‘blood famine’ drives patients to the black market

By Alexandra Harney SHANGHAI (Reuters) – China’s rising demand for healthcare is exposing a chronic shortage of an essential commodity: blood. With hospital blood supplies tight, desperate patients are turning to agents known as “blood heads”, who sell certificates that give patients access to state blood banks, creating a black market at the heart of the healthcare system. “If there were no blood heads, what would I do?” The blood “famine”, as it has been dubbed, is an unintended consequence of China’s attempts to restore faith in the nation’s scandal-stained blood supply and encourage people to donate. In the late 1980s and 1990s, local officials urged farmers to sell their blood and plasma, and an earlier generation of blood heads sold this to hospitals and blood banks.

U.S. eyes China partnership on Africa power – sources

By Joe Brock JOHANNESBURG (Reuters) – The United States is considering partnering with China on improving electricity in Africa and the proposal could be part of bilateral discussions when President Barack Obama visits Beijing next week, two sources involved told Reuters. The proposal could include $5-$7 billion of commitments to improve electricity generation and transmission in several African countries, one source involved in the initiative said. …